| J9299 | Injection, nivolumab, 1 mg | 11,400 | $20 | $273.6K |
| J9271 | Injection, pembrolizumab, 1 mg | 6,200 | $40 | $272.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,250 | $30 | $76.5K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,220 | $20 | $46.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 540 | $60 | $34.4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,210 | $30 | $31.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 180 | $110 | $19.9K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 240 | $50 | $12.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 100 | $100 | $9.3K |
| J9041 | Injection, bortezomib, 0.1 mg | 1,110 | $10 | $5.5K |